{"Q": 1, "answer": "no", "rationale": "The segment describes a vaccine deal but contains no intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_8484", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain any high-potency verbs, potent metaphors, critical alert phrases, superlatives + negative nouns, or intensifiers + harm nouns.", "method": "llm_batch", "batch_id": "batch_2_19464", "batch_size": 200, "batch_pos": 3, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "No moderate verb from the list.", "method": "llm_batch", "batch_id": "batch_3_21312", "batch_size": 200, "batch_pos": 142, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19100", "batch_size": 200, "batch_pos": 138, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports facts neutrally; lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_4476", "batch_size": 200, "batch_pos": 135, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "'up to 665,000' is not a minimiser.", "method": "llm_batch", "batch_id": "batch_6_19992", "batch_size": 200, "batch_pos": 104, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_3812", "batch_size": 200, "batch_pos": 81, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes details of a deal to secure vaccines ('deal secures up to 665,000 doses', 'option for a further 40 million vaccines') which is preparedness, without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_19976", "batch_size": 200, "batch_pos": 135, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
